Foghorn Therapeutics Inc. (FHTX) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 3.27M | 9.25M | 8.15M | 7.56M | 5.95M | 2.86M | 7.81M | 6.89M | 5.05M | 5.77M | 17.48M | 5.6M |
| Revenue Growth % | -45.11% | 223.77% | 4.42% | 9.71% | 17.86% | -50.49% | -55.33% | 23.02% | -4.88% | 37.88% | 163.46% | 24.7% |
| Cost of Goods Sold | 238K | 802K | 20M | 900K | 0 | 0 | 0 | 0 | 0 | 852K | 26.25M | 29.25M |
| COGS % of Revenue | 7.29% | 8.67% | 245.33% | 11.91% | - | - | - | - | - | 14.77% | 150.19% | 522.38% |
| Gross Profit | 3.03M | 8.45M | -11.85M | 6.66M | 5.95M | 2.86M | 7.81M | 6.89M | 5.05M | 4.92M | -8.77M | -23.65M |
| Gross Margin % | 92.72% | 91.33% | -145.33% | 88.09% | 100% | 100% | 100% | 100% | 100% | 85.23% | -50.19% | -422.38% |
| Gross Profit Growth % | -49.11% | 195.69% | -251.75% | -3.35% | 17.86% | -41.92% | 189% | 129.13% | -4.88% | 120.47% | 56.77% | -10.08% |
| Operating Expenses | 24.6M | 28.04M | 6.65M | 27.75M | 28.86M | 26.86M | 31.66M | 33.52M | 33.24M | 30.38M | 8.31M | 8.4M |
| OpEx % of Revenue | 753.05% | 303.24% | 81.59% | 367.26% | 484.96% | 940.51% | 405.48% | 486.64% | 658.3% | 526.52% | 47.53% | 150.04% |
| Selling, General & Admin | 6.58M | 6.8M | 6.65M | 6.86M | 7.24M | 6.35M | 6.97M | 7.33M | 7.71M | 7.02M | 8.31M | 8.4M |
| SG&A % of Revenue | 201.44% | 73.5% | 81.59% | 90.8% | 121.62% | 222.44% | 89.28% | 106.34% | 152.67% | 121.72% | 47.53% | 150.04% |
| Research & Development | 18.26M | 22.95M | 20M | 20.89M | 21.63M | 20.51M | 24.69M | 23.8M | 25.53M | 23.35M | 26.25M | 29.25M |
| R&D % of Revenue | 558.89% | 248.15% | 245.33% | 276.46% | 363.34% | 718.07% | 316.2% | 345.48% | 505.62% | 404.8% | 150.19% | 522.38% |
| Other Operating Expenses | -238K | -1000K | -1000K | 0 | 0 | 0 | 0 | 1000K | 0 | 0 | -1000K | -1000K |
| Operating Income | -21.57M | -19.6M | -18.5M | -21.1M | -22.91M | -24M | -23.85M | -26.63M | -28.19M | -25.46M | -17.08M | -32.05M |
| Operating Margin % | -660.33% | -211.92% | -226.92% | -279.17% | -384.96% | -840.51% | -305.48% | -386.64% | -558.3% | -441.29% | -97.73% | -572.42% |
| Operating Income Growth % | 5.85% | 18.37% | 22.43% | 20.78% | 18.73% | 5.71% | -39.64% | 16.9% | 15.38% | 20.16% | 39.56% | -9.81% |
| EBITDA | -21.34M | -18.79M | -17.65M | -20.2M | -22.09M | -23.24M | -23.12M | -25.84M | -27.36M | -24.61M | -16.22M | -31.17M |
| EBITDA Margin % | -653.05% | -203.24% | -216.47% | -267.26% | -371.07% | -813.87% | -296.09% | -375.16% | -541.76% | -426.52% | -92.79% | -556.78% |
| EBITDA Growth % | 3.4% | 19.14% | 23.66% | 21.84% | 19.27% | 5.54% | -42.56% | 17.11% | 15.71% | 20.72% | 40.85% | -9.89% |
| D&A (Non-Cash Add-back) | 238K | 802K | 852K | 900K | 827K | 761K | 733K | 791K | 835K | 852K | 864K | 876K |
| EBIT | -21.57M | -19.6M | -15.85M | -17.94M | -22.91M | -24M | -23.85M | -24.23M | -28.19M | -25.46M | -17.08M | -32.05M |
| Net Interest Income | 1.74M | 1.71M | 2.03M | 2.31M | 2.69M | 3.1M | 3.5M | 2.87M | 2.44M | 2.66M | 2.75M | 2.79M |
| Interest Income | 1.74M | 1.71M | 2.03M | 2.31M | 2.69M | 3.1M | 3.5M | 2.87M | 2.44M | 2.66M | 2.75M | 2.79M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.7M | -2.07M | 2.65M | 3.16M | 4.08M | 4.5M | 4.73M | 3.65M | 3.18M | 3.34M | 3.47M | 3.5M |
| Pretax Income | -19.88M | -21.66M | -15.85M | -17.94M | -18.83M | -19.5M | -19.12M | -22.98M | -25.02M | -22.12M | -13.61M | -28.55M |
| Pretax Margin % | -608.36% | -234.28% | -194.39% | -237.34% | -316.43% | -682.88% | -244.9% | -333.61% | -495.37% | -383.43% | -77.85% | -509.82% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.99M | 738K | 942K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -8.98% | -5.42% | -3.3% |
| Net Income | -19.88M | -21.66M | -15.85M | -17.94M | -18.83M | -19.5M | -19.12M | -22.98M | -25.02M | -24.11M | -14.35M | -29.49M |
| Net Margin % | -608.36% | -234.28% | -194.39% | -237.34% | -316.43% | -682.88% | -244.9% | -333.61% | -495.37% | -417.85% | -82.07% | -526.65% |
| Net Income Growth % | -5.53% | -11.08% | 17.12% | 21.95% | 24.71% | 19.09% | -33.3% | 22.07% | 17.95% | 16.55% | 44.33% | -7.96% |
| Net Income (Continuing) | -19.88M | -21.66M | -15.85M | -17.94M | -18.83M | -19.5M | -19.12M | -22.98M | -25.02M | -24.11M | -14.35M | -29.49M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.29 | -0.35 | -0.25 | -0.28 | -0.30 | -0.31 | -0.31 | -0.45 | -0.59 | -0.57 | -0.34 | -0.70 |
| EPS Growth % | 3.33% | -12.9% | 19.35% | 37.78% | 49.15% | 45.61% | 8.82% | 35.71% | 19.18% | 30.49% | 39.29% | -6.06% |
| EPS (Basic) | -0.29 | -0.35 | -0.25 | -0.28 | -0.30 | -0.31 | -0.31 | -0.45 | -0.59 | -0.57 | -0.34 | -0.70 |
| Diluted Shares Outstanding | 69.54M | 62.98M | 63.03M | 62.98M | 62.85M | 62.6M | 62.6M | 51.58M | 42.43M | 42.28M | 42.03M | 41.83M |
| Basic Shares Outstanding | 69.54M | 62.98M | 63.03M | 62.98M | 62.85M | 62.6M | 62.6M | 51.58M | 42.43M | 42.28M | 42.03M | 41.83M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |